Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations

被引:172
作者
Iacob, Simona A. [1 ,2 ]
Iacob, Diana G. [2 ]
Jugulete, Gheorghita [1 ,2 ]
机构
[1] Univ Med & Pharm Carol Davila, Infect Dis Dept, Bucharest, Romania
[2] Natl Inst Infect Dis Matei Bals, Bucharest, Romania
关键词
adherence; HIV; antiretroviral drugs; key affected population; antiretroviral treatment; adverse reactions; SELF-REPORTED ADHERENCE; INFECTED DRUG-USERS; MEDICATION ADHERENCE; VIRAL SUPPRESSION; ALCOHOL-CONSUMPTION; SOCIAL SUPPORT; UNITED-STATES; RISK; ADULTS; SEX;
D O I
10.3389/fphar.2017.00831
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
HIV infection is responsible for one the most devastating human pandemics. The advent of antiretroviral therapy has changed the course of the pandemic and saved millions of lives. Complex therapeutic regimens have been introduced since 1996 and have contributed to the transformation of HIV infection into a treatable chronic diseases. New types of potent antiretrovirals and their combinations, including "once daily" treatment, have simplified the regimens and diminished side effects. Nevertheless the adherence to antiretroviral therapy remains unsatisfactory and varies between 27 and 80% across different population in various studies, compared with the required level of 95%. The lack of adherence to antiretroviral therapy is a multi-factorial and dynamic process which raises considerable difficulties for long-term follow-up. Current solutions to this problem are complex. These should be applied by a multidisciplinary team and should take into account key features related to both the individual and social factors as well as to the population to whom it belongs (children, teenagers, elderly, marginalized population like drug users, incarcerated patients, sex workers, etc.). Importantly, adherence should continue to be monitored even in patients known to be compliant. In case of subsequent failure the team should identify the reasons for non-adherence and apply the appropriate methods. Where usual methods have no chance of success, a coordinated package of services also known as "harm reduction" can be offered in order to reduce the risks of transmission. The current article analyses the concept of adherence to antiretroviral therapy, the shortcomings of this medication and the methods that can be applied in practice to increase adherence. Emphasis is placed on the analysis of groups at high risk for HIV infection that currently represent the spearhead with which the HIV pandemic is spreading.
引用
收藏
页数:12
相关论文
共 88 条
[1]  
ABC Project Team, 2018, AS BARR COMPL POL SA
[2]   HealthCall: Technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients - a pilot study [J].
Aharonovich, Efrat ;
Greenstein, Eliana ;
O'Leary, Ann ;
Johnston, Barbara ;
Seol, Simone G. ;
Hasin, Deborah S. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2012, 24 (12) :1461-1469
[3]  
ALTICE FL, 2007, CLIN INFECT DIS, V45, P770, DOI DOI 10.1086/521166
[4]  
[Anonymous], 2014, The Gap Report
[5]  
[Anonymous], 2015, AIDS by the numbers 2015
[6]  
[Anonymous], 2001, ADH LONG TERM THER P
[7]  
[Anonymous], 2013, UNAIDS REP GLOB AIDS
[8]   Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study [J].
Arage, Getachew ;
Tessema, Gizachew Assefa ;
Kassa, Hiwot .
BMC PUBLIC HEALTH, 2014, 14
[9]   Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users [J].
Arnsten, JH ;
Demas, PA ;
Grant, RW ;
Gourevitch, MN ;
Farzodegan, H ;
Howard, AA ;
Schoenboum, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) :377-381
[10]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423